logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10537516 B1

PDFFull Text
Date of Patent:
Jan. 21, 2020

Filed:

Apr. 26, 2018

Composition for treating skin pigmentation and related methods

Applicant:

Access Business Group International Llc, Ada, MI (US);

Inventors:

Yi Zhang, Shanghai, CN;

Qiang Han, Shanghai, CN;

Tingzhao Li, Shanghai, CN;

Assignee:

ACCESS BUSINESS GROUP INTERNATIONAL LLC, Ada, MI (US);

Attorney:

Warner Norcross + Judd LLP

Primary Examiner:

Robert A Wax

Assistant Examiner:

Melissa S Mercier

Int. Cl.
CPC ...
A61Q 19/02 (2006.01); A61K 8/9783 (2017.01); A61K 8/63 (2006.01); A61K 8/49 (2006.01); A61K 8/368 (2006.01); A61K 8/92 (2006.01); A61K 8/34 (2006.01); A61K 8/9789 (2017.01); A61K 8/9794 (2017.01); A61K 8/06 (2006.01); A61K 8/02 (2006.01); A61K 8/04 (2006.01);
U.S. Cl.
CPC ...
A61K 8/9783 (2017.08); A61K 8/345 (2013.01); A61K 8/368 (2013.01); A61K 8/49 (2013.01); A61K 8/4926 (2013.01); A61K 8/4986 (2013.01); A61K 8/63 (2013.01); A61K 8/922 (2013.01); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61Q 19/02 (2013.01); A61K 8/022 (2013.01); A61K 8/042 (2013.01); A61K 8/046 (2013.01); A61K 8/062 (2013.01); A61K 8/064 (2013.01);
Abstract

A composition for treating skin pigmentation, a method of forming the composition, and a method of treating skin pigmentation are disclosed. The composition comprises at least one pharmaceutically acceptable additive. The composition further comprises at least one melanin production inhibitor, which may be a depigmentation agent. The melanin production inhibitor is present in an amount effective to inhibit melanin production in human skin cells of a subject that is administered the composition. The melanin production inhibitor is selected from the group consisting of cyclovirobuxine D, lipoic acid, nuciferine, peimisine, oleuropein,extract,(Regel) Maxim extract,etextract,extract,semen extract,extract,semen extract,semen extract,extract,semen extract,semen extract,extract,seed extract,extract,extract,extract,extract, and combinations thereof.

Find Patent Forward Citations

Loading…